Back

[18F]FDG PET/CT as a novel imaging biomarker in the diagnosis of anthracycline cardiotoxicity in hematologic patients.

19 May 2024 (09:00 - 12:00)
Organised by: Logo
Congress Presentation Part of: Poster session on nuclear imaging (1) Inflammation, Infection, and Infiltrative Cardiovascular Disorders Open Access International Conference on Nuclear Cardiology and Cardiac CT 2024 European Association of Cardiovascular Imaging (EACVI)

About the speaker

Photo
Doctor Marika Kalnina

Riga (Latvia)

24 More presentations in this session

Presentation thumbnail
Myocardial ischemia: beyond the normal perfusion images
Doctor O. Masoli (Buenos Aires, AR)
Abstract
Presentation thumbnail
Combination of CZT SPECT stress myocardial blood flow (MBF) and coronary artery calcium (CAC) scoring - opportunity for stress-first/stress-only protocol
Doctor M. Kaminek (Olomouc, CZ)
Abstract
Presentation thumbnail
CZT SPECT regional myocardial flow reserve: can it enhance risk stratification?
Associate Professor C. Mesquita (Niteroi, BR)
Abstract
Presentation thumbnail
Diagnostic strategies including cardiac SPECT/CT for women with known or suspected coronary artery disease. Data from Latvian cardiac SPECT/CT registry
Doctor B. Vitola (Riga, LV)
Abstract
Presentation thumbnail
Adverse events profile of regadenoson in patients with end-stage lung disease candidates for lung transplantation
Doctor C. Salgado (Huelva, ES)
Abstract

Access the full session

Session thumbnail
Poster session on nuclear imaging (1)

The Event

Event poster

International Conference on Nuclear Cardiology and Cardiac CT 2024

19 May - 21 May 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources